CPT code 81238: F9 sequencing, full gene sequence2026 Medicare lab fee · Clinical Laboratory Fee Schedule
Full-gene F9 sequencing identifies variants associated with factor IX deficiency and is reported when evaluating suspected hemophilia B or familial risk.
Medicare pays $600.00 for 81238 under the 2026 Clinical Laboratory Fee Schedule: one national amount, the same in every state and setting.
Medicare lab fee · CLFS 2026 Q4
National CLFS amount
$600.00
In effect since Jan 1, 2026. The same amount in every state, payment locality and setting.
- Geographic adjustment
- None
- Office vs facility
- Same
- Since 2020
- Unchanged
- CMS updates
- Quarterly
Medicare pays the lesser of the lab’s charge and this amount. Patients usually owe no Part B deductible or coinsurance for covered clinical lab tests.
On this page 7 sections
What 81238 covers
This molecular genetic test examines the F9 gene for sequence changes associated with reduced or absent coagulation factor IX and hemophilia B. A molecular diagnostic laboratory may perform it when clinicians evaluate suspected inherited factor IX deficiency or investigate a familial F9 condition. Results can support a molecular diagnosis and evaluation of relatives when appropriate.
Report 81238 for full-gene F9 analysis; it is distinct from factor IX activity testing and testing limited to a known familial variant. Medicare pays the test through the CLFS at one national amount per code in every state and locality, without geographic or office-versus-facility adjustment. The 2026 national CLFS amount is $600.00, unchanged since 2020. Payment is through the CLFS only, with no separate physician fee schedule payment for interpretation.
This summary was written with AI assistance from CMS Clinical Laboratory Fee Schedule data. Amounts on this page come directly from CMS files.
How Medicare pays 81238
Clinical lab tests aren’t priced like physician services. They’re paid from their own fee schedule, with its own rules. See the whole lab fee schedule.
One national amount
CMS sets a single Clinical Laboratory Fee Schedule amount for 81238. There’s no geographic (GPCI) adjustment, so it pays the same in every state and payment locality.
No office or facility rate
Lab tests aren’t built from relative value units, so there’s no office and facility split: the place of service doesn’t change the CLFS amount.
Updated every quarter
CMS republishes the CLFS each quarter. New tests, often proprietary laboratory analyses (PLA codes), join during the year; existing amounts are updated each January.
Excluded from the physician fee schedule
The physician fee schedule lists 81238 with status X (excluded by statute), so the test itself is paid only from the CLFS.
81238 on the lab fee schedule since 2020
81238 · CLFS 2026 Q4 (current)
$600.00
Unchanged since Jan 1, 2020
27 quarterly CLFS releases on file, first CLFS 2020 Q1. A code missing from a quarter wasn’t on that release.
81238 compared with similar tests
- 85250Factor IX testPTC or Christmas factor$19.04
- This is a factor IX activity test, not analysis of the F9 gene. Use it to measure factor function or level.
81238 billing questions
What does 81238 analyze?
It analyzes the full F9 gene for sequence changes associated with factor IX deficiency, including hemophilia B.
When should 81238 be chosen instead of a factor IX activity test?
Use 81238 for full-gene molecular analysis of F9. A factor IX activity test measures the clotting factor’s function or level.
Does 81238 describe testing limited to a known familial variant?
No. 81238 describes full-gene F9 analysis; testing limited to a known familial variant has a different testing scope.
How does Medicare pay for 81238?
Medicare pays it through the CLFS at one national amount per code across states and localities, without an office-versus-facility adjustment.
Where this amount comes from
FeeBase reads lab amounts directly from the CMS Clinical Laboratory Fee Schedule file for the quarter: one row per code, with its payment indicator and national amount. Contractor-priced tests are labeled, never given a made-up amount. Amounts are Medicare payment limits, not a patient’s bill or a commercial rate.
CMS CLFS 2026 Q4 · effective Oct 1, 2026 through the day before Jan 1, 2027
Show the CMS file line behind this amount
Fee sheets · Coming soon
Put 81238 and the rest of your codes on one sheet
Your codes at your locality, with payer contracts beside Medicare.
Join the waitlist